Average Co-Inventor Count = 4.33
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Teneobio, Inc. (7 from 9 patents)
2. Therapeutic Human Polyclonals Inc. (5 from 9 patents)
3. Teneoone, Inc. (3 from 3 patents)
4. Teneotwo, Inc. (2 from 2 patents)
5. The United States of America, As Represented by the Secretary, Department of Health and Human Services (3,539 patents)
17 patents:
1. 12371505 - Anti-BCMA heavy chain-only antibodies
2. 12202898 - Heavy chain antibodies binding to CD19
3. 12180298 - Heavy chain antibodies binding to PSMA
4. 11970540 - Anti-BCMA heavy chain-only antibodies
5. 11873336 - Heavy chain antibodies binding to CD22
6. 11613572 - CD3 binding antibodies
7. 11505606 - CD3 binding antibodies
8. 11434299 - Anti-BCMA heavy chain-only antibodies
9. 11427642 - Anti-BCMA heavy chain-only antibodies
10. 11421027 - CD3 binding antibodies
11. 11390681 - Multispecific heavy chain antibodies with modified heavy chain constant regions
12. 11186639 - Multispecific heavy chain antibodies with modified heavy chain constant regions
13. RE47131 - Humanized immunoglobulin loci
14. 8652842 - Humanized immunoglobulin loci
15. 8410333 - Humanized immunoglobulin loci